Assyro AI

Orange Book product · Generic (ANDA)

SOLIFENACIN SUCCINATE

SOLIFENACIN SUCCINATE

Generic (ANDA)ANDA 211423TE ABRX RISING
View SOLIFENACIN SUCCINATE familyOpen on FDA Orange Book

At a glance

Dec 11, 2019

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 11, 2019

    6 yr 7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SOLIFENACIN SUCCINATE

Strength

5MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 211423

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SOLIFENACIN SUCCINATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo